Table 1:

Participant demographic data, neurocognitive scores, and fractional brain volumea

HC (n = 19)RRMS-NI (n = 19)RRMS-I (n = 20)
Demographics
    Age (yr)49.0 ± 7.146.4 ± 7.248.1 ± 4.7
    Female sex (No.) (%)14 (73.68)15 (78.95)12 (60)
    Education (yr)16.9 ± 2.9b16.1 ± 1.314.6 ± 1.9b
    Disease duration (yr)0.0 ± 0.011.8 ± 5.411.6 ± 4.9
    HADS-A (log) (median) (IQR)3 (1–6)b,c6 (5–7)c8 (7–10)b
    HADS-D (log) (median) (IQR)2 (1–3)b3 (1,5)d8 (6–10)b,d
    EDSS median (IQR)NA1.5 (1–2)d2.5 (2–3)d
Percentage fractional brain volume
    BPF79 ± 9b75 ± 672 ± 8b
    fC45.15 ± 5.1243.43 ± 3.9141.87 ± 5.50
    fWM31.66 ± 4.07b29.61 ± 2.8328.35 ± 3.5b
    fCL0.00 ± 0.00b0.01 ± 0.010.01 ± 0.02b
    fBG1.35 ± 0.191.31 ± 0.181.25 ± 0.22
    fTh0.68 ± 0.12b0.64 ± 0.140.55 ± 0.14b
    fWML0.00 ± 0.00b0.67 ± 0.740.92 ± 0.90b
    fT1 hole0.00 ± 0.00b0.23 ± 0.220.410 ± 0.506b
    fCSF21.16 ± 8.78b24.10 ± 6.2426.64 ± 7.32b
  • Note:—HADS indicates Hospital Anxiety [A] and Depression [D] Scale; EDSS, Extended Disability Status Scale; BPF, brain parenchymal fraction; fC, fractional cortical volume; fWM, fractional white matter volume; fCL, fractional cortical lesions volume; fBG, fractional basal ganglia volume; fTh, fractional thalamus volume; fWML, fractional white matter lesions volume; fTI hole, fractional T1 hole volume; fCSF, fractional CSF volume; HC, healthy controls; NA, not applicable; IQR, interquartile range.

  • a All values are means unless otherwise specified. Significant P value < .017.

  • b HC vs RRMS-I.

  • c HC vs RRMS-NI.

  • d RRMS-NI vs RRMS-I.